Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2018-2033)
2.2 Molecular Diagnostics in Infectious Disease Testing Growth Trends by Region
2.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2024-2033)
2.3 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2018-2023)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2022
3.5 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2024-2033)
5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2033)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023)
6.4 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2033)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023)
7.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2033)
8.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2033)
9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023)
9.4 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2033)
10.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.2.5 BD Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.3.5 BioMerieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Siemens
11.6.1 Siemens Company Detail
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.6.5 Siemens Recent Development
11.7 Veridex
11.7.1 Veridex Company Detail
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Detail
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.10.5 Qiagen Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Detail
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Detail
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
11.12.5 BioTheranostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Key Players of Microarrays
Table 5. Key Players of Next-Generation Sequencing (NGS)
Table 6. Key Players of Hybridization
Table 7. Key Players of Others
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2018-2023)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2024-2033)
Table 14. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 15. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 16. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 17. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2018-2023)
Table 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
Table 21. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 25. Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2018-2023)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2024-2033)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2018-2023)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2024-2033)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2024-2033) & (US$ Million)
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Molecular Diagnostics in Infectious Disease Testing Product
Table 53. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. BD Company Detail
Table 56. BD Business Overview
Table 57. BD Molecular Diagnostics in Infectious Disease Testing Product
Table 58. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 59. BD Recent Development
Table 60. BioMerieux Company Detail
Table 61. BioMerieux Business Overview
Table 62. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
Table 63. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 64. BioMerieux Recent Development
Table 65. Thermo Fisher Scientific Company Detail
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
Table 68. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 69. Thermo Fisher Scientific Recent Development
Table 70. Roche Company Detail
Table 71. Roche Business Overview
Table 72. Roche Molecular Diagnostics in Infectious Disease Testing Product
Table 73. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Siemens Company Detail
Table 76. Siemens Business Overview
Table 77. Siemens Molecular Diagnostics in Infectious Disease Testing Product
Table 78. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 79. Siemens Recent Development
Table 80. Veridex Company Detail
Table 81. Veridex Business Overview
Table 82. Veridex Molecular Diagnostics in Infectious Disease Testing Product
Table 83. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 84. Veridex Recent Development
Table 85. Luminex Company Detail
Table 86. Luminex Business Overview
Table 87. Luminex Molecular Diagnostics in Infectious Disease Testing Product
Table 88. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 89. Luminex Recent Development
Table 90. GenMark Diagnostics Company Detail
Table 91. GenMark Diagnostics Business Overview
Table 92. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
Table 93. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 94. GenMark Diagnostics Recent Development
Table 95. Qiagen Company Detail
Table 96. Qiagen Business Overview
Table 97. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
Table 98. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 99. Qiagen Recent Development
Table 100. Genomix Biotech Company Detail
Table 101. Genomix Biotech Business Overview
Table 102. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product
Table 103. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 104. Genomix Biotech Recent Development
Table 105. BioTheranostics Company Detail
Table 106. BioTheranostics Business Overview
Table 107. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product
Table 108. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 109. BioTheranostics Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2022 VS 2033
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 5. Microarrays Features
Figure 6. Next-Generation Sequencing (NGS) Features
Figure 7. Hybridization Features
Figure 8. Others Features
Figure 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Academic Institutes Case Studies
Figure 14. Laboratories Case Studies
Figure 15. Others Case Studies
Figure 16. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region: 2022 VS 2033
Figure 20. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2022
Figure 21. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2022
Figure 23. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2018-2033)
Figure 25. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2018-2033)
Figure 29. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2018-2033)
Figure 37. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2018-2033)
Figure 45. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2018-2033)
Figure 49. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 52. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 53. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 55. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 56. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 57. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 58. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 59. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 60. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 61. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 62. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed